Share This:
Search Results
The DNTP Technical Report (TR) Level of Evidence Criteria are available here: https://ntp.niehs.nih.gov/go/baresults. In the table below this information is further delineated into three fields:
- Level of Evidence: The overall category of evidence of carcinogenic activity for the TR, Species, Strain and Sex
- Organ Site Call: The level of evidence supported by the specific organ site for the TR, Species, Strain and Sex. When the Organ Site Call directly supports the TR Level Of Evidence the Finding Type flag is set to “Neoplastic Lesion”. Some Organ Site Calls could support a separate call of Equivocal Evidence; this is noted in Finding Type by the flag “May Have Been Related”
- Finding Type: Further identification of the Organ Site Call. Where this says “Neoplastic Lesion” the Organ Site Call supports the TR Level of Evidence and the Organ Site Call is the same as that of the TR. Where Finding Type says “May Have Been Related” the TR Level of Evidence for other responses led to an overall call of Clear or Some Evidence but the specified organ supports a call of Equivocal Evidence.
Exact Match | Publication No. | CASRN | Test Article Name | Species | Strain | Sex | Route | Organ | Level of Evidence | Organ Site Call | Tumor Type/Incidence | Finding Type |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Yes | TR-006 | 18662-53-8 | Nitrilotriacetic acid trisodium monohydrate | Rats | F344/N | Male | Dosed-Feed | Kidney Transitional Cell | Positive | Positive | CARCINOMA | Neoplastic Lesions |
Yes | TR-089 | 134-29-2 | o-Anisidine hydrochloride | Rats | F344/N | Male | Dosed-Feed | Kidney Transitional Cell | Positive | Positive | CARCINOMA | Neoplastic Lesions |
Yes | TR-423 | 119-84-6 | 3,4-Dihydrocoumarin | Rats | F344/N | Male | Gavage | Kidney Transitional Cell | Some Evidence | Equivocal Evidence | CARCINOMA 0/50 0/48 0/47 2/50 | May Have Been Related |
Yes | TR-367 | 50-33-9 | Phenylbutazone | Rats | F344/N | Female | Gavage | Kidney Transitional Cell | Some Evidence | Some Evidence | CARCINOMA 0/50 0/50 2/50 | Neoplastic Lesions |
Yes | TR-416 | 91-23-6 | o-Nitroanisole | Rats | F344/N | Female | Dosed-Feed | Kidney Transitional Cell | Clear Evidence | Clear Evidence | (STOP STUDY) PAPILLOMA 0/60 0/60 1/60 OR CARCINOMA 0/60 0/60 1/60 | Neoplastic Lesions |
Yes | TR-416 | 91-23-6 | o-Nitroanisole | Rats | F344/N | Male | Dosed-Feed | Kidney Transitional Cell | Clear Evidence | Clear Evidence | PAPILLOMA (STOP STUDY) 0/60 0/60 4/60 OR CARCINOMA 0/60 1/60 8/60 | Neoplastic Lesions |
Yes | TR-335 | 6373-74-6 | C.I. Acid Orange 3 | Rats | F344/N | Female | Gavage | Kidney Transitional Cell | Clear Evidence | Clear Evidence | CARCINOMA 0/50 0/50 6/50 | Neoplastic Lesions |
Yes | TR-323 | 756-79-6 | Dimethyl methylphosphonate | Rats | F344/N | Male | Gavage | Kidney Transitional Cell | Some Evidence | Some Evidence | PAPILLOMA 0/50 7/50 3/49 | Neoplastic Lesions |
Yes | TR-313 | 2385-85-5 | Mirex | Rats | F344/N | Male | Dosed-Feed | Kidney Transitional Cell | Clear Evidence | Clear Evidence | PAPILLOMA 0/51 0/51 0/52 0/52 1/51 3/52 | Neoplastic Lesions |
Yes | TR-494 | 84-65-1 | Anthraquinone | Rats | F344/N | Male | Dosed-Feed | Kidney Transitional Cell | Some Evidence | Some Evidence | PAPILLOMA 0/50 0/50 2/50 0/50 1/50 | Neoplastic Lesions |
Yes | TR-457 | 599-79-1 | Salicylazosulfapyridine | Rats | F344/N | Female | Gavage | Kidney Transitional Cell | Some Evidence | Some Evidence | PAPILLOMA 0/50 0/50 0/50 2/50 | Neoplastic Lesions |
Exact Match | Publication No. | CASRN | Test Article Name | Species | Strain | Sex | Route | Organ | Level of Evidence | Organ Site Call | Tumor Type/Incidence | Finding Type |
---|---|---|---|---|---|---|---|---|---|---|---|---|
No | TR-423 | 119-84-6 | 3,4-Dihydrocoumarin | Mice | B6C3F1 | Male | Gavage | Unspecified | No Evidence | Not applicable | Not applicable | |
Yes | TR-423 | 119-84-6 | 3,4-Dihydrocoumarin | Rats | F344/N | Male | Gavage | Kidney Transitional Cell | Some Evidence | Equivocal Evidence | CARCINOMA 0/50 0/48 0/47 2/50 | May Have Been Related |
No | TR-423 | 119-84-6 | 3,4-Dihydrocoumarin | Rats | F344/N | Male | Gavage | Kidney Tubular Cell | Some Evidence | Some Evidence | ADENOMA 0/50 1/48 0/47 2/50, STEP SECTIONS 1/50 0/48 3/47 5/50 | Neoplastic Lesions |
No | TR-423 | 119-84-6 | 3,4-Dihydrocoumarin | Mice | B6C3F1 | Female | Gavage | Liver | Some Evidence | Some Evidence | ADENOMA 10/51 20/50 22/50 20/52 OR CARCINOMA 3/51 2/50 4/50 6/52 COMBINED 13/51 21/50 25/50 24/52 | Neoplastic Lesions |
Yes | TR-494 | 84-65-1 | Anthraquinone | Rats | F344/N | Male | Dosed-Feed | Kidney Transitional Cell | Some Evidence | Some Evidence | PAPILLOMA 0/50 0/50 2/50 0/50 1/50 | Neoplastic Lesions |
No | TR-494 | 84-65-1 | Anthraquinone | Rats | F344/N | Female | Dosed-Feed | Kidney Tubular Cell | Clear Evidence | Clear Evidence | ADENOMA 0/50 4/50 9/50 7/50 12/49; ADENOMA OR CARCINOMA 0/50 6/50 9/50 8/50 14/49 | Neoplastic Lesions |
No | TR-494 | 84-65-1 | Anthraquinone | Rats | F344/N | Male | Dosed-Feed | Kidney Tubular Cell | Some Evidence | Some Evidence | ADENOMA 1/50 3/50 9/50 5/50 3/50 | Neoplastic Lesions |
No | TR-494 | 84-65-1 | Anthraquinone | Rats | F344/N | Male | Dosed-Feed | Liver | Some Evidence | Equivocal Evidence | ADENOMA OR CARCINOMA 1/50 3/50 4/50 5/50 3/50 | May Have Been Related |
No | TR-494 | 84-65-1 | Anthraquinone | Mice | B6C3F1 | Female | Dosed-Feed | Liver | Clear Evidence | Clear Evidence | ADENOMA 6/49 28/50 27/50 40/49 OR CARCINOMA 2/49 3/50 8/50 8/49 COMBINED 6/49 30/50 30/50 41/49 | Neoplastic Lesions |
No | TR-494 | 84-65-1 | Anthraquinone | Mice | B6C3F1 | Male | Dosed-Feed | Liver | Clear Evidence | Clear Evidence | ADENOMA 21/50 32/50 38/50 41/49 OR CARCINOMA 8/50 13/50 17/50 21/49 OR HEPATOBLASTOMA 1/50 6/50 11/50 37/49 COMBINED 26/50 35/50 43/50 48/49 | Neoplastic Lesions |
No | TR-494 | 84-65-1 | Anthraquinone | Rats | F344/N | Female | Dosed-Feed | Liver | Clear Evidence | Clear Evidence | ADENOMA 0/50 2/50 6/50 4/50 3/50 | Neoplastic Lesions |
No | TR-494 | 84-65-1 | Anthraquinone | Mice | B6C3F1 | Female | Dosed-Feed | Thyroid Gland Follicular Cell | Clear Evidence | Equivocal Evidence | ADENOMA 1/45 1/48 2/48 2/48 OR CARCINOMA 0/45 0/48 0/48 2/48 COMBINED 1/45 1/48 2/48 4/48 | May Have Been Related |
No | TR-494 | 84-65-1 | Anthraquinone | Mice | B6C3F1 | Male | Dosed-Feed | Thyroid Gland Follicular Cell | Clear Evidence | Equivocal Evidence | ADENOMA 0/50 0/50 2/49 2/46 | May Have Been Related |
No | TR-494 | 84-65-1 | Anthraquinone | Rats | F344/N | Female | Dosed-Feed | Urinary Bladder | Clear Evidence | Clear Evidence | TRANSITIONAL EPITHELIAL PAPILLOMA OR CARCINOMA 0/49 0/49 0/49 1/50 2/49 | Neoplastic Lesions |
No | TR-494 | 84-65-1 | Anthraquinone | Rats | F344/N | Male | Dosed-Feed | Urinary Bladder | Some Evidence | Some Evidence | TRANSITIONAL EPITHELIAL PAPILLOMA 0/50 1/50 3/50 7/50 3/49 | Neoplastic Lesions |
Yes | TR-335 | 6373-74-6 | C.I. Acid Orange 3 | Rats | F344/N | Female | Gavage | Kidney Transitional Cell | Clear Evidence | Clear Evidence | CARCINOMA 0/50 0/50 6/50 | Neoplastic Lesions |
No | TR-323 | 756-79-6 | Dimethyl methylphosphonate | Mice | B6C3F1 | Male | Gavage | Unspecified | Inadequate Study | Not applicable | Not applicable | |
No | TR-323 | 756-79-6 | Dimethyl methylphosphonate | Mice | B6C3F1 | Female | Gavage | Unspecified | No Evidence | Not applicable | Not applicable | |
No | TR-323 | 756-79-6 | Dimethyl methylphosphonate | Rats | F344/N | Female | Gavage | Unspecified | No Evidence | Not applicable | Not applicable | |
No | TR-323 | 756-79-6 | Dimethyl methylphosphonate | Rats | F344/N | Male | Gavage | Hematopoietic System | Some Evidence | Equivocal Evidence | LEUKEMIA 10/50 11/50 17/50 | May Have Been Related |
Yes | TR-323 | 756-79-6 | Dimethyl methylphosphonate | Rats | F344/N | Male | Gavage | Kidney Transitional Cell | Some Evidence | Some Evidence | PAPILLOMA 0/50 7/50 3/49 | Neoplastic Lesions |
No | TR-323 | 756-79-6 | Dimethyl methylphosphonate | Rats | F344/N | Male | Gavage | Kidney Tubular Cell | Some Evidence | Some Evidence | ADENOCARCINOMA 0/50 2/50 3/49 | Neoplastic Lesions |
No | TR-313 | 2385-85-5 | Mirex | Rats | F344/N | Male | Dosed-Feed | Adrenal Gland Medulla | Clear Evidence | Clear Evidence | PHEOCHROMOCYTOMA 8/51 7/52 13/52 11/52 18/51 19/51 | Neoplastic Lesions |
No | TR-313 | 2385-85-5 | Mirex | Rats | F344/N | Female | Dosed-Feed | Hematopoietic System | Clear Evidence | Clear Evidence | LEUKEMIA 6/52 9/52 14/52 | Neoplastic Lesions |
Yes | TR-313 | 2385-85-5 | Mirex | Rats | F344/N | Male | Dosed-Feed | Kidney Transitional Cell | Clear Evidence | Clear Evidence | PAPILLOMA 0/51 0/51 0/52 0/52 1/51 3/52 | Neoplastic Lesions |
No | TR-313 | 2385-85-5 | Mirex | Rats | F344/N | Female | Dosed-Feed | Liver | Clear Evidence | Clear Evidence | NEOPLASTIC NODULE 2/52 23/52 30/52 | Neoplastic Lesions |
No | TR-313 | 2385-85-5 | Mirex | Rats | F344/N | Male | Dosed-Feed | Liver | Clear Evidence | Clear Evidence | NEOPLASTIC NODULE 3/52 5/52 5/52 14/52 15/52 26/52 | Neoplastic Lesions |
No | TR-006 | 139-13-9 | Nitrilotriacetic acid (NTA) | Mice | B6C3F1 | Female | Dosed-Feed | Kidney Tubular Cell | Positive | Positive | ADENOCARCINOMA | Neoplastic Lesions |
No | TR-006 | 139-13-9 | Nitrilotriacetic acid (NTA) | Mice | B6C3F1 | Male | Dosed-Feed | Kidney Tubular Cell | Positive | Positive | ADENOCARCINOMA | Neoplastic Lesions |
No | TR-006 | 139-13-9 | Nitrilotriacetic acid (NTA) | Rats | F344/N | Male | Dosed-Feed | Kidney Tubular Cell | Positive | Positive | ADENOMA OR ADENOCARCINOMA | Neoplastic Lesions |
No | TR-006 | 139-13-9 | Nitrilotriacetic acid (NTA) | Rats | F344/N | Male | Dosed-Feed | Ureter | Positive | Positive | (ADENOMA OR PAPILLOMA) | Neoplastic Lesions |
No | TR-006 | 139-13-9 | Nitrilotriacetic acid (NTA) | Rats | F344/N | Female | Dosed-Feed | Urinary Bladder | Positive | Positive | (TRANSITIONAL CELL CARCINOMA) | Neoplastic Lesions |
No | TR-006 | 18662-53-8 | Nitrilotriacetic acid trisodium monohydrate | Mice | B6C3F1 | Female | Dosed-Feed | Unspecified | Negative | Not applicable | Not applicable | |
No | TR-006 | 18662-53-8 | Nitrilotriacetic acid trisodium monohydrate | Mice | B6C3F1 | Male | Dosed-Feed | Unspecified | Negative | Not applicable | Not applicable | |
No | TR-006 | 18662-53-8 | Nitrilotriacetic acid trisodium monohydrate | Rats | F344/N | Male | Dosed-Feed | Kidney Transitional Cell | Equivocal Evidence | Equivocal | PAPILLOMA | Neoplastic Lesions |
Yes | TR-006 | 18662-53-8 | Nitrilotriacetic acid trisodium monohydrate | Rats | F344/N | Male | Dosed-Feed | Kidney Transitional Cell | Positive | Positive | CARCINOMA | Neoplastic Lesions |
No | TR-006 | 18662-53-8 | Nitrilotriacetic acid trisodium monohydrate | Rats | F344/N | Male | Dosed-Feed | Kidney Tubular Cell | Equivocal Evidence | Equivocal | ADENOCARCINOMA | Neoplastic Lesions |
No | TR-006 | 18662-53-8 | Nitrilotriacetic acid trisodium monohydrate | Rats | F344/N | Female | Dosed-Feed | Kidney Tubular Cell | Positive | Positive | ADENOMA OR ADENOCARCINOMA | Neoplastic Lesions |
No | TR-006 | 18662-53-8 | Nitrilotriacetic acid trisodium monohydrate | Rats | F344/N | Male | Dosed-Feed | Kidney Tubular Cell | Positive | Positive | ADENOCARCINOMA OR CARCINOMA | Neoplastic Lesions |
No | TR-006 | 18662-53-8 | Nitrilotriacetic acid trisodium monohydrate | Rats | F344/N | Female | Dosed-Feed | Ureter | Positive | Positive | (TRANSITIONAL CELL CARCINOMA) | Neoplastic Lesions |
No | TR-006 | 18662-53-8 | Nitrilotriacetic acid trisodium monohydrate | Rats | F344/N | Male | Dosed-Feed | Ureter | Positive | Positive | (TRANSITIONAL CELL CARCINOMA) | Neoplastic Lesions |
No | TR-006 | 18662-53-8 | Nitrilotriacetic acid trisodium monohydrate | Rats | F344/N | Female | Dosed-Feed | Urinary Bladder | Equivocal Evidence | Equivocal | (TRANSITIONAL CELL CARCINOMA) | Neoplastic Lesions |
No | TR-006 | 18662-53-8 | Nitrilotriacetic acid trisodium monohydrate | Rats | F344/N | Female | Dosed-Feed | Urinary Bladder | Positive | Positive | (TRANSITIONAL CELL CARCINOMA) | Neoplastic Lesions |
Yes | TR-089 | 134-29-2 | o-Anisidine hydrochloride | Rats | F344/N | Male | Dosed-Feed | Kidney Transitional Cell | Positive | Positive | CARCINOMA | Neoplastic Lesions |
No | TR-089 | 134-29-2 | o-Anisidine hydrochloride | Rats | F344/N | Male | Dosed-Feed | Thyroid Gland Follicular Cell | Positive | Positive | ADENOMA OR CARCINOMA | Neoplastic Lesions |
No | TR-089 | 134-29-2 | o-Anisidine hydrochloride | Mice | B6C3F1 | Female | Dosed-Feed | Urinary Bladder | Positive | Positive | (TRANSITIONAL CELL PAPILLOMA, TRANSITIONAL CELL CARCINOMA) | Neoplastic Lesions |
No | TR-089 | 134-29-2 | o-Anisidine hydrochloride | Mice | B6C3F1 | Male | Dosed-Feed | Urinary Bladder | Positive | Positive | (TRANSITIONAL CELL PAPILLOMA, TRANSITIONAL CELL CARCINOMA) | Neoplastic Lesions |
No | TR-089 | 134-29-2 | o-Anisidine hydrochloride | Rats | F344/N | Female | Dosed-Feed | Urinary Bladder | Positive | Positive | (TRANSITIONAL CELL PAPILLOMA, TRANSITIONAL CELL CARCINOMA) | Neoplastic Lesions |
No | TR-089 | 134-29-2 | o-Anisidine hydrochloride | Rats | F344/N | Male | Dosed-Feed | Urinary Bladder | Positive | Positive | (TRANSITIONAL CELL PAPILLOMA, TRANSITIONAL CELL CARCINOMA) | Neoplastic Lesions |
No | TR-416 | 91-23-6 | o-Nitroanisole | Rats | F344/N | Female | Dosed-Feed | Forestomach | Clear Evidence | Equivocal Evidence | SQUAMOUS CELL PAPILLOMA 0/50 1/50 0/50 1/50 | May Have Been Related |
No | TR-416 | 91-23-6 | o-Nitroanisole | Rats | F344/N | Male | Dosed-Feed | Forestomach | Clear Evidence | Equivocal Evidence | SQUAMOUS CELL PAPILLOMA O/50 0/50 1/50 1/50; SQUAMOUS CELL CARCINOMA 0/50 0/50 1/50 1/50 | May Have Been Related |
No | TR-416 | 91-23-6 | o-Nitroanisole | Rats | F344/N | Female | Dosed-Feed | Hematopoietic System | Clear Evidence | Clear Evidence | MONONUCLEAR CELL LEUKEMIA 14/50 11/50 14/50 26/50 | Neoplastic Lesions |
No | TR-416 | 91-23-6 | o-Nitroanisole | Rats | F344/N | Male | Dosed-Feed | Hematopoietic System | Clear Evidence | Clear Evidence | MONONUCLEAR CELL LEUKEMIA 26/50 25/50 42/50 34/50 | Neoplastic Lesions |
No | TR-416 | 91-23-6 | o-Nitroanisole | Rats | F344/N | Female | Dosed-Feed | Intestines (Large) | Clear Evidence | Clear Evidence | (STOP STUDY) ADENOMATOUS POLYP 0/60 8/60 18/60, CARCINOMA 0/60 0/60 2/60 | Neoplastic Lesions |
No | TR-416 | 91-23-6 | o-Nitroanisole | Rats | F344/N | Male | Dosed-Feed | Intestines (Large) | Clear Evidence | Clear Evidence | (STOP STUDY) ADENOMATOUS POLYP 0/60 26/60 30/60, CARCINOMA 0/60 0/60 5/60 | Neoplastic Lesions |
Yes | TR-416 | 91-23-6 | o-Nitroanisole | Rats | F344/N | Female | Dosed-Feed | Kidney Transitional Cell | Clear Evidence | Clear Evidence | (STOP STUDY) PAPILLOMA 0/60 0/60 1/60 OR CARCINOMA 0/60 0/60 1/60 | Neoplastic Lesions |
Yes | TR-416 | 91-23-6 | o-Nitroanisole | Rats | F344/N | Male | Dosed-Feed | Kidney Transitional Cell | Clear Evidence | Clear Evidence | PAPILLOMA (STOP STUDY) 0/60 0/60 4/60 OR CARCINOMA 0/60 1/60 8/60 | Neoplastic Lesions |
No | TR-416 | 91-23-6 | o-Nitroanisole | Rats | F344/N | Male | Dosed-Feed | Kidney Tubular Cell | Clear Evidence | Equivocal Evidence | ADENOMA 0/49 1/50 1/50 1/49 OR CARCINOMA 0/49 0/50 0/50 2/49 | May Have Been Related |
No | TR-416 | 91-23-6 | o-Nitroanisole | Mice | B6C3F1 | Male | Dosed-Feed | Liver | Clear Evidence | Clear Evidence | ADENOMA 14/50 26/50 41/50 29/50; CARCINOMA 7/50 12/50 11/50 7/50; HEPATOBLASTOMA 0/50 3/50 17/50 9/50 | Neoplastic Lesions |
No | TR-416 | 91-23-6 | o-Nitroanisole | Mice | B6C3F1 | Female | Dosed-Feed | Liver | Some Evidence | Some Evidence | ADENOMA 14/50 2/50 36/50 18/50 | Neoplastic Lesions |
No | TR-416 | 91-23-6 | o-Nitroanisole | Rats | F344/N | Female | Dosed-Feed | Urinary Bladder | Clear Evidence | Clear Evidence | (STOP STUDY) TRANSITIONAL CELL PAPILLOMA 0/58 2/59 1/60, TRANSITIONAL CELL CARCINOMA 0/58 28/59 48/60 | Neoplastic Lesions |
No | TR-416 | 91-23-6 | o-Nitroanisole | Rats | F344/N | Male | Dosed-Feed | Urinary Bladder | Clear Evidence | Clear Evidence | (STOP STUDY) TRANSITIONAL CELL PAPILLOMA 0/59 9/59 1/60, TRANSITIONAL CELL CARCINOMA 0/59 27/59 50/60, SQUAMOUS CELL PAPILLOMA 0/59 0/59 4/60, SQUAMOUS CELL CARCINOMA 0/59 0/59 6/60, SARCOMA 0/59 2/59 9/60 | Neoplastic Lesions |
No | TR-367 | 50-33-9 | Phenylbutazone | Mice | B6C3F1 | Female | Gavage | Unspecified | No Evidence | Not applicable | Not applicable | |
Yes | TR-367 | 50-33-9 | Phenylbutazone | Rats | F344/N | Female | Gavage | Kidney Transitional Cell | Some Evidence | Some Evidence | CARCINOMA 0/50 0/50 2/50 | Neoplastic Lesions |
No | TR-367 | 50-33-9 | Phenylbutazone | Rats | F344/N | Female | Gavage | Kidney Tubular Cell | Some Evidence | Equivocal Evidence | ADENOMA (STEP SECTIONS) 0/50 3/50 1/50 OR CARCINOMA 0/50 1/50 0/50 COMBINED 0/50 4/50 1/50 | May Have Been Related |
No | TR-367 | 50-33-9 | Phenylbutazone | Rats | F344/N | Male | Gavage | Kidney Tubular Cell | Equivocal Evidence | Equivocal Evidence | ADENOMA 0/50 0/49 3/50 OR CARCINOMA 0/50 1/49 0/50 COMBINED 0/50 1/49 3/50 | Neoplastic Lesions |
No | TR-367 | 50-33-9 | Phenylbutazone | Mice | B6C3F1 | Male | Gavage | Liver | Some Evidence | Some Evidence | ADENOMA 8/50 12/50 24/50 OR CARCINOMA 8/50 4/50 11/50 COMBINED 16/50 14/50 31/50 | Neoplastic Lesions |
Yes | TR-457 | 599-79-1 | Salicylazosulfapyridine | Rats | F344/N | Female | Gavage | Kidney Transitional Cell | Some Evidence | Some Evidence | PAPILLOMA 0/50 0/50 0/50 2/50 | Neoplastic Lesions |
No | TR-457 | 599-79-1 | Salicylazosulfapyridine | Mice | B6C3F1 | Female | Gavage | Liver | Clear Evidence | Clear Evidence | ADENOMA 12/50 28/50 25/50 28/49 OR CARCINOMA 2/50 10/50 10/50 9/49 COMBINED 14/50 32/50 28/50 29/49 | Neoplastic Lesions |
No | TR-457 | 599-79-1 | Salicylazosulfapyridine | Mice | B6C3F1 | Male | Gavage | Liver | Clear Evidence | Clear Evidence | ADENOMA 13/50 32/50 28/50 42/50 OR CARCINOMA 13/50 15/50 23/50 8/50 COMBINED 24/50 38/50 38/50 44/50 | Neoplastic Lesions |
No | TR-457 | 599-79-1 | Salicylazosulfapyridine | Rats | F344/N | Female | Gavage | Urinary Bladder | Some Evidence | Some Evidence | TRANSITIONAL CELL PAPILLOMA 0/49 0/50 2/50 0/50 | Neoplastic Lesions |
No | TR-457 | 599-79-1 | Salicylazosulfapyridine | Rats | F344/N | Male | Gavage | Urinary Bladder | Some Evidence | Some Evidence | (CORE STUDY) TRANSITIONAL CELL PAPILLOMA 0/50 0/49 2/50 6/50 | Neoplastic Lesions |